Carbapenemase-producing Enterobacterales: a profound threat to Australian public health
- PMID: 37660307
- DOI: 10.5694/mja2.52077
Carbapenemase-producing Enterobacterales: a profound threat to Australian public health
Keywords: Anti-infective agents; Drug resistance; Microbiology; Prevention and control; Public health; microbial.
References
-
- Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629-655.
-
- Karakonstantis S, Kritsotakis EI, Gikas A. Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options. J Antimicrob Chemother 2019; 75: 271-282.
-
- Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018; 18: 318-327.
-
- Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25: 682-707.
-
- Nordmann P, Mariotte S, Naas T, et al. Biochemical properties of a carbapenem- beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother 1993; 37: 939-946.
LinkOut - more resources
Full Text Sources